Henri M. Garrison-Desany,Jacquelyn L. Meyers,Sarah D. Linnstaedt,Stacey L. House,Francesca L. Beaudoin,Xinming An,Donglin Zeng,Thomas C. Neylan,Gari D. Clifford,Tanja Jovanovic,Laura T. Germine,Kenneth A. Bollen,Scott L. Rauch,John P. Haran,Alan B. Storrow,Christopher Lewandowski,Paul I. Musey,Phyllis L. Hendry,Sophia Sheikh,Christopher W. Jones,Brittany E. Punches,Robert A. Swor,Nina T. Gentile,Lauren A. Hudak,Jose L. Pascual,Mark J. Seamon,Erica Harris,Claire Pearson,David A. Peak,Robert M. Domeier,Niels K. Rathlev,Brian J. O’Neil,Paulina Sergot,Leon D. Sanchez,Steven E. Bruce,Jutta Joormann,Steven E. Harte,Samuel A. McLean,Karestan C. Koenen,Christy A. Denckla

Abstract:Background: Post-traumatic stress disorder (PTSD) and substance use (tobacco, alcohol, and cannabis) are highly comorbid. Many factors affect this relationship, including sociodemographic and psychosocial characteristics, other prior traumas, and physical health. However, few prior studies have investigated this prospectively, examining new substance use and the extent to which a wide range of factors may modify the relationship to PTSD. Methods: The Advancing Understanding of RecOvery afteR traumA (AURORA) study is a prospective cohort of adults presenting at emergency departments (N = 2,943). Participants self-reported PTSD symptoms and the frequency and quantity of tobacco, alcohol, and cannabis use at six total timepoints. We assessed the associations of PTSD and future substance use, lagged by one timepoint, using the Poisson generalized estimating equations. We also stratified by incident and prevalent substance use and generated causal forests to identify the most important effect modifiers of this relationship out of 128 potential variables. Results: At baseline, 37.3% (N = 1,099) of participants reported likely PTSD. PTSD was associated with tobacco frequency (incidence rate ratio (IRR): 1.003, 95% CI: 1.00, 1.01, p = 0.02) and quantity (IRR: 1.01, 95% CI: 1.001, 1.01, p = 0.01), and alcohol frequency (IRR: 1.002, 95% CI: 1.00, 1.004, p = 0.03) and quantity (IRR: 1.003, 95% CI: 1.001, 1.01, p = 0.001), but not with cannabis use. There were slight differences in incident compared to prevalent tobacco frequency and quantity of use; prevalent tobacco frequency and quantity were associated with PTSD symptoms, while incident tobacco frequency and quantity were not. Using causal forests, lifetime worst use of cigarettes, overall self-rated physical health, and prior childhood trauma were major moderators of the relationship between PTSD symptoms and the three substances investigated. Conclusion: PTSD symptoms were highly associated with tobacco and alcohol use, while the association with prospective cannabis use is not clear. Findings suggest that understanding the different risk stratification that occurs can aid in tailoring interventions to populations at greatest risk to best mitigate the comorbidity between PTSD symptoms and future substance use outcomes. We demonstrate that this is particularly salient for tobacco use and, to some extent, alcohol use, while cannabis is less likely to be impacted by PTSD symptoms across the strata.

Molecular Toxicology and Pathophysiology of Comorbid Alcohol Use Disorder and Post-Traumatic Stress Disorder Associated with Traumatic Brain Injury

Comorbidity of Post-Traumatic Stress Disorder and Alcohol Use Disorder: Animal Models and Associated Neurocircuitry

Post-traumatic stress disorder (PTSD) symptoms and alcohol and drug use comorbidity at 25 US level I trauma centers

Temporal differential effects of post-injury alcohol consumption in a mouse model of blast-induced traumatic brain injury

Elucidating the Neurobiologic Etiology of Comorbid PTSD and Substance Use Disorders

Alcohol-exacerbates post-traumatic stress psychiatric behavior and its neuropathological sequalae in experimental mice: preventive effects of morin

State of the Science: Treatment of comorbid posttraumatic stress disorder and substance use disorders

Connecting the Pathology of Posttraumatic Stress and Substance Use Disorders: Monoamines and Neuropeptides

Integrating Drug Target Information in Deep Learning Models to Predict the Risk of Adverse Events in Patients with Comorbid Post-Traumatic Stress Disorder and Alcohol Use Disorder

Traumatic Brain Injury Exacerbates Alcohol Consumption and Neuroinflammation with Decline in Cognition and Cholinergic Activity

Genomic risk for post-traumatic stress disorder in families densely affected with alcohol use disorders

Psychopharmacological interaction of alcohol and posttraumatic stress disorder: Effective action of naringin

Investigating the Behavioral and Biological Effects of Chronic Alcohol Use in a Mouse Model of Blast-Induced Mild Traumatic Brain Injury

Potential causal effect of posttraumatic stress disorder on alcohol use disorder and alcohol consumption in individuals of European descent: A Mendelian Randomization Study

The Risk Factors of the Alcohol Use Disorders—Through Review of Its Comorbidities

Network approach to the symptom-level association between alcohol use disorder and posttraumatic stress disorder

A systematic review and meta-analysis of psychological interventions for comorbid post-traumatic stress disorder and substance use disorder

Prediction of Adverse Events Risk in Patients with Comorbid Post-Traumatic Stress Disorder and Alcohol Use Disorder Using Electronic Medical Records by Deep Learning Models

Alcohol use disorder as a moderator of the relationship between posttraumatic stress disorder and suicidality among military personnel

Transdiagnostic Mood, Anxiety, and Trauma Symptom Factors in Alcohol Use Disorder: Neural Correlates Across 3 Brain Networks

Post-traumatic stress and future substance use outcomes: leveraging antecedent factors to stratify risk